Diagnosis and assessment of pulmonary arterial hypertension.

The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area, with changes occurring in the definition of the disease, screening and diagnostic techniques, and staging and follow-up assessment. The definition of pulmonary hypertension has been simplified, and is now based on currently available evidence. There has been substantial progress in advancing the imaging techniques and biomarkers used to screen patients for the disease and to follow up their response to therapy. The importance of accurate assessment of right ventricular function in following up the clinical course and response to therapy is more fully appreciated. As new therapies are developed for pulmonary arterial hypertension, screening, prompt diagnosis, and accurate assessment of disease severity become increasingly important. A clear definition of pulmonary hypertension and the development of a rational approach to diagnostic assessment and follow-up using both conventional and new tools will be essential to deriving maximal benefit from our expanding therapeutic armamentarium.

[1]  B. Hamm,et al.  Comparison of Electron Beam Computed Tomography With Magnetic Resonance Imaging in Assessment of Right Ventricular Volumes and Function , 2004, Journal of computer assisted tomography.

[2]  V. Fuster,et al.  Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.

[3]  M. Humbert,et al.  Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. , 2010, European heart journal.

[4]  R. Naeije,et al.  Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. , 2005, American journal of physiology. Heart and circulatory physiology.

[5]  J. Parker,et al.  A hemodynamic study of acute coronary insufficiency precipitated by exercise. With observations on the effects of nitroglycerin. , 1966, The American journal of cardiology.

[6]  R. Coleman,et al.  Regulation of Stroke Volume during Submaximal and Maximal Upright Exercise in Normal Man , 1986, Circulation research.

[7]  D. Mccrory,et al.  Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[8]  S. Rich,et al.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.

[9]  W. H. Herbert,et al.  Pulmonary circulation in the aged. , 1967, Journal of applied physiology.

[10]  W. Hildebrandt,et al.  Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. , 2000, Journal of the American College of Cardiology.

[11]  K. Hossack,et al.  Atrial natriuretic factor production during upright exercise. , 1990, Cardiology.

[12]  Horst Olschewski,et al.  Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. , 2004, European heart journal.

[13]  O. Castro,et al.  Pulmonary hypertension in sickle cell disease. , 2011, The American journal of cardiology.

[14]  J. Bronzwaer,et al.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. , 2007, European heart journal.

[15]  J. Rivier,et al.  [Exercise test and cardiac catheterization]. , 1957, Cardiologia.

[16]  M. Humbert,et al.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. , 2005, Arthritis and rheumatism.

[17]  A. Jánosi,et al.  Pulmonary artery pressure and oxygen consumption measurement during supine bicycle exercise. , 1988, Chest.

[18]  M. Pillinger,et al.  Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension , 2006 .

[19]  E. Trulock,et al.  Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  R. Souza,et al.  [Clinical characteristics of pulmonary hypertension patients in two reference centers in the city of Sao Paulo]. , 2006, Revista da Associacao Medica Brasileira.

[21]  D. Badesch,et al.  Ambrisentan therapy for pulmonary arterial hypertension. , 2005, Journal of the American College of Cardiology.

[22]  S. Rich,et al.  Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.

[23]  R. Speich,et al.  HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study. , 1997, American journal of respiratory and critical care medicine.

[24]  A. Branzi,et al.  A meta-analysis of randomized controlled trials in pulmonary arterial hypertension , 2008, European heart journal.

[25]  Horst Olschewski,et al.  Magnetic Resonance–Derived 3-Dimensional Blood Flow Patterns in the Main Pulmonary Artery as a Marker of Pulmonary Hypertension and a Measure of Elevated Mean Pulmonary Arterial Pressure , 2008, Circulation. Cardiovascular imaging.

[26]  Boxt Lm.  MR imaging of pulmonary hypertension and right ventricular dysfunction. , 1996 .

[27]  K. Hossack,et al.  Maximal cardiac output during upright exercise: approximate normal standards and variations with coronary heart disease. , 1980, The American journal of cardiology.

[28]  J. Widimský,et al.  The Effect of Age on the Pressure-flow Relationship and on the Capacity of the Pulmonary Vascular Bed with Special Reference to the Condition of High Flow , 1970 .

[29]  J. Sandoval,et al.  Survival in primary pulmonary hypertension. Validation of a prognostic equation. , 1994, Circulation.

[30]  L. Ekelund,et al.  Circulatory and Respiratory Adaptation, during Long‐Term, Non‐Steady State Exercise, in the Sitting Position1 , 1964 .

[31]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[32]  E. Braunwald,et al.  Characterization of the Circulatory Response to Maximal Upright Exercise in Normal Subjects and Patients with Heart Disease , 1967, Circulation.

[33]  V. Perifanis,et al.  Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. , 2004, Haematologica.

[34]  J. Bronzwaer,et al.  Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. , 2007, Chest.

[35]  P. Light,et al.  Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility , 2007, Circulation.

[36]  B. Groves,et al.  A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.

[37]  N. Rajagopalan,et al.  Tricuspid Annular Systolic Velocity: A Useful Measurement in Determining Right Ventricular Systolic Function Regardless of Pulmonary Artery Pressures , 2006, Echocardiography.

[38]  J. Hickam,et al.  EFFECT OF EXERCISE ON CARDIAC OUTPUT AND PULMONARY ARTERIAL PRESSURE IN NORMAL PERSONS AND IN PATIENTS WITH CARDIOVASCULAR DISEASE AND PULMONARY EMPHYSEMA. , 1948, The Journal of clinical investigation.

[39]  A. Esterman,et al.  Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation , 2006, Internal medicine journal.

[40]  G. Koch,et al.  Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension , 1997 .

[41]  R. Dore,et al.  Pulmonary hypertension: role of computed tomography and magnetic resonance imaging. , 2005, Italian heart journal : official journal of the Italian Federation of Cardiology.

[42]  S. Kimmel,et al.  Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. , 2003, Chest.

[43]  K. Rühle,et al.  [Hemodynamics, plasma catecholamine behavior and beta-adrenergic receptor density in trained and untrained subjects and cardiac insufficiency patients]. , 1983, Zeitschrift fur Kardiologie.

[44]  H. Gurtner,et al.  [The hemodynamics of healthy students at rest and under graduated work load]. , 1967, Medicina thoracalis.

[45]  K. Donald,et al.  The effect of exercise on the cardiac output and circulatory dynamics of normal subjects. , 1955, Clinical science.

[46]  A. Holmgren,et al.  CIRCULATORY AND RESPIRATORY ADAPTATION, DURING LONG-TERM, NON-STEADY STATE EXERCISE, IN THE SITTING POSITION. , 1964, Acta physiologica Scandinavica.

[47]  K. Kangawa,et al.  Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.

[48]  G. Simonneau,et al.  Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. , 2008, American journal of respiratory and critical care medicine.

[49]  K. G. Balakrishnan,et al.  Primary pulmonary hypertension: natural history and prognostic factors. , 1994, Indian heart journal.

[50]  A. Torbicki,et al.  Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. , 2006, Chest.

[51]  Avid,et al.  BOSENTAN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION , 2002 .

[52]  A. Hadengue,et al.  Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. , 1991, Gastroenterology.

[53]  Paolo Prandoni,et al.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.

[54]  A. Fishman,et al.  Effects of Acute Hypoxia and Exercise on the Pulmonary Circulation , 1960, Circulation.

[55]  G. Gaul,et al.  Comparison of supine and sitting body position during a triangular exercise test , 1977, European Journal of Applied Physiology and Occupational Physiology.

[56]  R. Riley,et al.  Studies of the pulmonary circulation at rest and during exercise in normal individuals and in patients with chronic pulmonary disease. , 1948, The American journal of physiology.

[57]  H. Zwick,et al.  [The normal range of the pulmonary artery pressure during ergometrical exercise (author's transl)]. , 1976, Medizinische Klinik.

[58]  M. Remy-Jardin,et al.  Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. , 2007, The Journal of rheumatology.

[59]  S. Doutreleau,et al.  Pulmonary hemodynamics during a strenuous intermittent exercise in healthy subjects. , 2003, Medicine and science in sports and exercise.

[60]  S. Kimmel,et al.  Hemodynamics and survival of patients with portopulmonary hypertension , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[61]  T. Welte,et al.  Goal-oriented treatment and combination therapy for pulmonary arterial hypertension , 2005, European Respiratory Journal.

[62]  A. Shillington,et al.  Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.

[63]  T. Ueland,et al.  N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. , 2006, The American journal of cardiology.

[64]  A Berghold,et al.  Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review , 2009, European Respiratory Journal.

[65]  T. Strandell,et al.  RELATIONSHIPS BETWEEN CARDIAC OUTPUT, STROKE VOLUME AND INTRACARDIAC PRESSURES AT REST AND DURING EXERCISE IN SUPINE POSITION AND SOME ANTHROPOMETRIC DATA IN HEALTHY OLD MEN. , 2009, Acta medica Scandinavica.

[66]  A. Lahad,et al.  Echocardiographic assessment of pulmonary hypertension in Gaucher's disease , 1998, The Lancet.

[67]  L. Hartley,et al.  Reduction of stroke volume during exercise in man following ascent to 3,100 m altitude. , 1967, Journal of applied physiology.

[68]  R. Barst,et al.  Survival with first-line bosentan in patients with primary pulmonary hypertension , 2005, European Respiratory Journal.

[69]  E. Paganini,et al.  Refractory congestive heart failure: overview and application of extracorporeal ultrafiltration. , 1996, Advances in renal replacement therapy.

[70]  M. Humbert,et al.  Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. , 2006, European heart journal.

[71]  T SJOSTRAND,et al.  Circulatory data in normal subjects at rest and during exercise in recumbent position, with special reference to the stroke volume at different work intensities. , 1960, Acta physiologica Scandinavica.

[72]  W. Laskey,et al.  Right ventricular-pulmonary arterial interactions , 2006, Annals of Biomedical Engineering.

[73]  M. Oberholzer,et al.  Influence of age on pulmonary haemodynamics at rest and during supine exercise. , 1983, Clinical science.

[74]  M. Mcgoon,et al.  The assessment of pulmonary hypertension. , 2001, Clinics in chest medicine.

[75]  M. Mehra,et al.  Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. , 2004, Congestive heart failure.

[76]  F. Loogen,et al.  [Hemodynamics of the pulmonary circulation during a multistep exercise test in healthy subjects]. , 1976, Die Medizinische Welt.

[77]  H. Denolin,et al.  Normal pulmonary pressure-flow relationship during exercise in the sitting position , 2004, Internationale Zeitschrift für angewandte Physiologie einschließlich Arbeitsphysiologie.

[78]  C. Lavie,et al.  Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. , 2002, Circulation.

[79]  D. Mccrory,et al.  Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[80]  T. Abraham,et al.  Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.

[81]  J. S. Bower,et al.  Pulmonary gas exchange during exercise in patients with chronic obliterative pulmonary hypertension. , 1984, The American review of respiratory disease.

[82]  M. Humbert,et al.  Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol , 2005, Thorax.

[83]  A HOLMGREN,et al.  Circulatory studies in well trained athletes at rest and during heavy exercise. With special reference to stroke volume and the influence of body position. , 1963, Acta physiologica Scandinavica.

[84]  D. Mccrory,et al.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[85]  T. Kuriyama,et al.  Prediction of life expectancy in patients with primary pulmonary hypertension. A retrospective nationwide survey from 1980-1990. , 1999, Internal medicine.

[86]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[87]  C S Houston,et al.  Operation Everest II: preservation of cardiac function at extreme altitude. , 1987, Journal of applied physiology.

[88]  M. Gladwin,et al.  Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension , 2005, British journal of haematology.

[89]  A J Tajik,et al.  Doppler echocardiographic index for assessment of global right ventricular function. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[90]  R. Barst,et al.  Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. , 2006, Journal of the American College of Cardiology.

[91]  B. Zilberstein,et al.  Prevalence of pulmonary hypertension in patients with hepatosplenic Mansonic schistosomiasis--prospective study. , 2003, Hepato-gastroenterology.

[92]  W. Ageno,et al.  Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. , 2006, Chest.

[93]  C. Denton,et al.  Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. , 2006, European heart journal.

[94]  Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.

[95]  A. Damato,et al.  Hemodynamic response to treadmill exercise in normal subjects. , 1966, Journal of applied physiology.

[96]  J. Widimský,et al.  EFFECT OF REPEATED EXERCISE ON THE LESSER CIRCULATION. , 1963, Journal of applied physiology.

[97]  C. Higgins,et al.  Evaluation of the right ventricle by magnetic resonance imaging. , 1987, American heart journal.

[98]  P. Arbogast,et al.  Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. , 2003, American journal of respiratory and critical care medicine.

[99]  E. Robin,et al.  PRIMARY PULMONARY HYPERTENSION , 2022 .

[100]  C. Fischer,et al.  Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene , 2000, Circulation.

[101]  B. Groves,et al.  Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. , 1987, Journal of applied physiology.

[102]  G. Simonneau,et al.  EFFECTS OF THE DUAL ENDOTHELIN RECEPTOR ANTAGONIST BOSENTAN IN PATIENTS WITH PULM HT: A RANDOMIZED PLACEBO CONTROLLED STUDY , 2001 .

[103]  M. Humbert,et al.  Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia , 2009, Circulation.

[104]  S. Inzucchi,et al.  Pulmonary hypertension caused by Graves' thyrotoxicosis: normal pulmonary hemodynamics restored by (131)I treatment. , 1999, Chest.

[105]  L. Ekelund,et al.  Circulatory and Respiratory Adaptation during Prolonged Exercise in the Supine Position , 1966 .

[106]  R. Naeije,et al.  Feasibility of routine pulmonary arterial impedance measurements in pulmonary hypertension. , 2004, Chest.

[107]  Gilles Garcia,et al.  Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.

[108]  Jeffrey L. Anderson,et al.  ACCF/AHA Expert Conseusus Document , 2009 .

[109]  J. Widimský,et al.  Central haemodynamics during supine exercise and pulmonary artery occlusion in normal subjects. , 1973, Bulletin de physio-pathologie respiratoire.

[110]  M N Sawka,et al.  Central hemodynamics during progressive upper- and lower-body exercise and recovery. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[111]  J. Mlczoch,et al.  [Pulmonary circulation as a limiting factor in physical work capacity (author's transl)]. , 1976, Pneumonologie. Pneumonology.

[112]  V. Fuster.  Hurst's the Heart , 1966 .

[113]  A. Bardají,et al.  Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. , 2005, The American journal of medicine.

[114]  L. Dexter,et al.  Effect of exercise on circulatory dynamics of normal individuals. , 1951, Journal of applied physiology.

[115]  B. Brundage,et al.  Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. , 1997, Journal of the American College of Cardiology.

[116]  Stuart Rich,et al.  Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease , 2000, Annals of Internal Medicine.

[117]  H. Tan,et al.  A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. , 2007, European heart journal.

[118]  L. Boxt.  MR imaging of pulmonary hypertension and right ventricular dysfunction. , 1996, Magnetic resonance imaging clinics of North America.

[119]  M. Yacoub,et al.  Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. , 1994, British heart journal.

[120]  L. Boxt,et al.  Magnetic Resonance Imaging for Quantitation of Right Ventricular Volume in Patients with Pulmonary Hypertension , 1993, Journal of thoracic imaging.

[121]  M F O'Rourke,et al.  Vascular impedance in studies of arterial and cardiac function. , 1982, Physiological reviews.

[122]  M. Humbert,et al.  Splenectomy and chronic thromboembolic pulmonary hypertension , 2005, Thorax.

[123]  N. Dean,et al.  Noninvasive Evaluation of Pulmonary Artery Pressure During Exercise by Saline-Enhanced Doppler Echocardiography in Chronic Pulmonary Disease , 1989, Circulation.

[124]  M. Schemper,et al.  Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension , 2005, Thrombosis and Haemostasis.

[125]  T. Medsger,et al.  Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. , 1986, Arthritis and rheumatism.

[126]  G. Kane.  Primary pulmonary hypertension in HIV infection. , 1992, Chest.

[127]  L N KATZ,et al.  Effect of training on response of cardiac output to muscular exercise in athletes. , 1955, Journal of applied physiology.

[128]  P. Flemming,et al.  Pulmonary Hypertension after Splenectomy? , 1999, Annals of Internal Medicine.

[129]  H. Denolin,et al.  The Effect of Age on Pulmonary Circulation in Normal Subjects , 1970 .

[130]  A. DeMaria,et al.  Noninvasive assessment of pulmonary vascular resistance using Doppler tissue imaging of the tricuspid annulus. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[131]  D. Pennell,et al.  Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. , 2005, American journal of respiratory and critical care medicine.

[132]  A. Cohen-Solal,et al.  Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study , 2003, Hepatology.

[133]  R. Naeije,et al.  Reflections on wave reflections in chronic thromboembolic pulmonary hypertension. , 2007, European heart journal.

[134]  C. Hernández,et al.  [Cardiovascular manifestations in progressive systemic sclerosis]. , 1985, Archivos del Instituto de Cardiologia de Mexico.

[135]  V. Perifanis,et al.  Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. , 2004, Haematologica.

[136]  L. Rubin,et al.  Primary pulmonary hypertension , 1998, The Lancet.

[137]  J. Parker,et al.  Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. , 1978, The American journal of cardiology.

[138]  H. Kreisman,et al.  Evaluation of right ventricular systolic pressure during incremental exercise by Doppler echocardiography in adults with atrial septal defect. , 1998, Chest.

[139]  R. Naeije,et al.  Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? , 2007, European Respiratory Journal.

[140]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[141]  M. Morpurgo,et al.  Pulmonary input impedance or pulmonary vascular resistance? , 1995, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[142]  T. Kunieda.  Primary pulmonary hypertension and its life prognosis. , 1999, Internal medicine.

[143]  J. Lamounier,et al.  Pulmonary hypertension in schistosomiasis mansoni. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[144]  G E Gale,et al.  Pulmonary gas exchange in humans exercising at sea level and simulated altitude. , 1986, Journal of applied physiology.

[145]  J B Seward,et al.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.

[146]  D. Gibson,et al.  Left ventricular filling characteristics in pulmonary hypertension: a new mode of ventricular interaction , 1992, British heart journal.

[147]  O. Balchum,et al.  The effect of mild exercise in the supine position on the pulmonary arterial pressure of five normal human subjects. , 1954, The Journal of clinical investigation.

[148]  M. Böhm,et al.  Current Therapy of Pulmonary Hypertension , 2005, Herz Kardiovaskuläre Erkrankungen.

[149]  R. Delsignore,et al.  Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. , 2006, European journal of internal medicine.

[150]  D. Badesch,et al.  Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. , 2007, Chest.

[151]  R. Wiesner,et al.  Portopulmonary hypertension: Results from a 10‐year screening algorithm , 2006, Hepatology.

[152]  Maurizio Marvisi,et al.  Distiroidismi e ipertensione polmonare , 2004 .

[153]  M. Yigla,et al.  Primary pulmonary hypertension in Israel: a national survey. , 2001, Chest.

[154]  Stress-Doppler-echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia , 2009 .

[155]  Orris,et al.  INHALED ILOPROST FOR SEVERE PULMONARY HYPERTENSION , 2002 .

[156]  D. Badesch,et al.  Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. , 1999, American journal of respiratory and critical care medicine.

[157]  M. Baron,et al.  Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. , 2005, The Journal of rheumatology.

[158]  N. Banchero,et al.  Pulmonary Pressure, Cardiac Output, and Arterial Oxygen Saturation during Exercise at High Altitude and at Sea Level , 1966, Circulation.

[159]  J. Bishop,et al.  The relation between pressure and flow in the pulmonary circulation in normal subjects and in patients with chronic bronchitis and mitral stenosis. , 1968, Cardiovascular research.

[160]  A HOLMGREN,et al.  The effect of body position on the circulation at rest and during exercise, with special reference to the influence on the stroke volume. , 1960, Acta physiologica Scandinavica.

[161]  B JONSSON,et al.  CIRCULATION IN HEALTHY OLD MEN, STUDIED BY RIGHT HEART CATHETERIZATION AT REST AND DURING EXERCISE IN SUPINE AND SITTING POSITION. , 2009, Acta medica Scandinavica.

[162]  D. James,et al.  Distensibility Characteristics of the Human Pulmonary Vascular Bed: Study of the Pressure‐Volume Response to Exercise in Patients with and without Heart Disease , 1967, Circulation.

[163]  J. Oh,et al.  The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[164]  M. Fontana,et al.  Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes , 2007, British journal of pharmacology.

[165]  L. Boxt,et al.  Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. , 1992, Journal of the American College of Cardiology.

[166]  W. Chung,et al.  [Genetics and genomics of pulmonary arterial hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[167]  L. Rakita,et al.  Response of pulmonary artery pressure and total pulmonary resistance of untrained, convalescent man to prolonged mild steady state exercise. , 1957, The Journal of clinical investigation.

[168]  N. Reichek,et al.  Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. , 1989, Circulation.

[169]  R. Hetzer,et al.  Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing , 2002, Circulation.

[170]  R. Redberg,et al.  Abnormal pulmonary artery pressure profile after cardiac transplantation: an exercise Doppler echocardiographic study. , 1995, American heart journal.

[171]  J. Lima,et al.  The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). , 2005, Arthritis and rheumatism.

[172]  M. Humbert,et al.  Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.

[173]  R. Naeije,et al.  False-positive diagnosis of pulmonary hypertension by Doppler echocardiography. , 1998, European Respiratory Journal.

[174]  H. Piene.  Pulmonary arterial impedance and right ventricular function. , 1986, Physiological reviews.

[175]  G. Koch,et al.  Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. , 1999, The American journal of cardiology.

[176]  K. Lewis.  Pulmonary Arterial Hypertension in France: Results from a National Registry , 2007 .

[177]  M. Fujita,et al.  Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. , 2000, American journal of respiratory and critical care medicine.

[178]  R. Naeije,et al.  How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. , 2007, American journal of respiratory and critical care medicine.

[179]  R. Naeije,et al.  High-Altitude–Induced Right-Heart Failure , 2007 .

[180]  B. Wiens,et al.  Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2 , 2008, Circulation.

[181]  P. Walser,et al.  Normal Values for Pulmonary Hemodynamics at Rest and during Exercise in Man , 1975 .

[182]  L. Jorfeldt,et al.  Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. , 1999, Circulation.